Edwards Lifesciences
1,242 hedge funds and large institutions have $41.1B invested in Edwards Lifesciences in 2023 Q1 according to their latest regulatory filings, with 135 funds opening new positions, 449 increasing their positions, 424 reducing their positions, and 99 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 1,225 → 1,242 (+17)
6% more repeat investments, than reductions
Existing positions increased: 449 | Existing positions reduced: 424
0.56% less ownership
Funds ownership: 82.15% → 81.59% (-0.56%)
Holders
1,242
Holding in Top 10
12
Calls
$174M
Puts
$140M
Top Buyers
| 1 | +$425M | |
| 2 | +$237M | |
| 3 | +$103M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$63.8M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
+$59.3M |
Top Sellers
| 1 | -$241M | |
| 2 | -$142M | |
| 3 | -$127M | |
| 4 |
Two Sigma Investments
New York
|
-$116M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$116M |